Skip to NavigationSkip to content

News

Novartis has submitted a second marketing application for its CAR-T therapy Kymriah with the FDA, this time in the treatment of relapsed or...
Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would sell its 50%...
New findings from Janssen showed a patient-reported improvement in Crohn's symptoms of the disease within one week of an intravenous infusion dose...
MSD has been forced to withdraw its EU marketing application for Keytruda in combination with pemetrexed and carboplatin in non-small cell lung...
AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for an...
Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce its...
Samsung Biologics has announced it has expanded its strategic alliance with MSD to streamline process development and clinical material production...
Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to the...
MSD to axe 1,800 in US, Celgene gives up on $710m inflammatory drug and Roche emereges as top pharma spender in new report. Check out the top ten...
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% of trusts across England. A report emerging from the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches